Molecular evolution of acute myeloid leukaemia in relapse: Unstable N- ras and FLT3 genes compared with p53 gene

British Journal of Haematology

Volumn 104, Issue 4, 1999, Pages 659-664

  Nakano, Yasuyuki ^a   Kiyoi, Hitoshi ^a   Miyawaki, Shuichi ^b   Asou, Norio ^c   Ohno, Ryuzo ^d   Saito, Hidehiko ^a   Naoe, Tomoki ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAISEIKAI MAEBASHI HOSPITAL   (Japan)

^c KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^d HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute myeloid leukaemia; FLT3; N ras; p53; Relapse

Indexed keywords

PROTEIN P53;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GENETICS; CANCER RECURRENCE; CANCER REGRESSION; CLINICAL ARTICLE; FEMALE; GENE DUPLICATION; GENE MUTATION; HUMAN; KARYOTYPE; MALE; MOLECULAR EVOLUTION; ONCOGENE N RAS; PRIORITY JOURNAL;

EID: 0033043084     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01256.x     Document Type: Article

References (26)

1. Ahuja, H., Bar-eli, M., Arlin, Z., Advani, S., Allen, S.L., Goldman, J., Snyder, D., Foti, A. & Cline, M. (1991) The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia. Journal of Clinical Investigation, 87, 2042-2047.
2. Bishop, J.F. (1997) The treatment of adult acute myeloid leukemia. Seminars in Oncology, 24, 57-69.
3. Burnett, A.K. & Eden, O.B. (1997) The treatment of acute leukaemia. Lancet, 349, 270-275.
4. Caligiuri, M.A., Strout, M.P. & Gilliland, D.G. (1997) Molecular biology of acute myeloid leukemia. Seminars in Oncology, 24, 32-44.
5. Estey, E., Keating, M.J., Pierce, S. & Stass, S. (1995) Change in karyotype between diagnosis and first relapse in acute myelogenous leukemia. Leukemia, 9, 972-976.
6. Farr, C.J., Saiki, R.K., Erlich, H.A., McCormik, F. & Marshall, C.J. (1988) Analysis of RAS gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotides probes. Proceedings of the National Academy of Sciences of the United States of America, 85, 1629-1633.
7. Fenaux, P., Preudhomme, C., Quiquandon, I., Jonveaux, P., Lai, J.L., Vanrumbeke, M., Loucheux-Lefebvre, M.H., Bauters, F., Berger, R. & Kerckaert, J.P. (1992) Mutations of the p53 gene in acute myeloid leukaemia. British Journal of Haematology, 80, 178-183.
8. Garson, O.M., Hagemeijer, A., Sakurai, M., Reeves, B.R., Swansbury, G.L., Williams, G.J., Alimena, G., Artur, D.C., Berger, R. & de la Chapella, A. (1989) Cytogenetic studies of 103 patients with acute myelogeneous leukaemia in relapse. Cancer Genetics and Cytogenetics, 40, 187-202.
9. Hirai, H., Kobayashi, Y., Mano, H., Hagiwara, K., Maru, Y., Omine, M., Mizoguchi, H., Nishida, J. & Takaku, F. (1987) A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome. Nature, 327, 430-432.
10. Horiike, S., Yokota, S., Nakao, M., Iwai, T., Sasai, Y., Kaneko, H., Taniwaki, M., Kashima, K., Fujii, H. & Abe, T. (1997) Tandem duplications of the FLT3 receptor gene are associated with leukemic transformation of myelodysplasia. Leukemia, 11, 1442-1446.
11. Hu, G., Zhang, W. & Deisseroth, A.B. (1992) P53 gene mutations in acute myelogeneous leukaemia. British Journal of Haematology, 81, 489-494.
12. Ivy, S.P., Olshefski, R.S., Taylor, B.J., Patel, K.M. & Reaman, G.H. (1996) Correlation of P-glycoprotein expression and function in childhood acute leukemia: a Children's Cancer Group study. Blood, 88, 309-318.
13. Jonveaux, P., Fenaux, P., Quiquandon, I., Pignon, J.M., Lai, J.L., Loucheux-Lefebvre, M.H., Goossens, M., Bauters, F. & Berger, R. (1991) Mutations of the P53 gene in myelodysplastic syndromes. Oncogene, 6, 2243-2247.
14. Kiyoi, H., Naoe, T., Yokota, S., Nakao, M., Minami, S., Kuriyama, K., Takeshita, A., Saito, K., Hasegawa, S., Shimodaira, S., Tamura, J., Shimazaki, C., Matue, K., Kobayashi, H., Arima, N., Suzuki, R., Morishita, H., Saito, H., Ueda, R., Ohno, R., and the leukaemia study group of the Ministry of Health and Welfare (1997) Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia, 11, 1447-1452.
15. Kiyoi, H., Towatari, M., Yokota, S., Hamaguchi, M., Ohno, R., Saito, H. & Naoe, T. (1998) Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product. Leukemia, 12, 1333-1337.
16. Kobayashi, T., Miyawaki, S., Tanimoto, M., Kuriyama, K., Murakami, H., Yoshida, M., Minami, S., Minato, K., Tsubaki, K. & Ohmoto, E. (1996) Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukaemia. The Japan Leukemia Study Group. Journal of Clinical Oncology, 14, 204-213.
17. Kubo, K., Naoe, T., Kiyoi, H., Fukutani, H., Kato, Y., Oguri, T., Yamamori, S., Akatsuka, Y., Kodera, Y. & Ohno, R. (1993) Clonal analysis of multiple point mutations in the N-ras gene in patients with acute myeloid leukaemia. Japanese Journal of Cancer Research, 84, 379-387.
18. Look, A.T. (1997) Oncogenic transcription factors in the human acute leukemias. Science, 278, 1059-1064.
19. Neubauer, A., Dodge, R.K., George, S.L., Davey, F.R., Silver, R.T. & Schiffer, C.A. (1994) Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia. Blood, 83, 1603-1611.
20. Ohno, R., Kobayashi, T., Tanimoto, M., Hiraoka, A., Imai, K., Asou, N., Tomonaga, M., Tsubaki, K., Takahashi, I. & Kodera, Y. (1993) Randomized study of individualized induction therapy with or without vincristine, and of maintenance-intensification therapy between 4 or 12 courses in adult acute myeloid leukaemia. AML-87 Study of the Japan Adult Leukemia Study Group. Cancer, 71, 3888-3895.
21. Ohno, R., Naoe, T., Kanamaru, A., Yoshida, M., Hiraoka, A., Kobayashi, T., Ueda, T., Minami, S., Morishima, Y. & Saito, Y. (1994) A double-blind controlled study of granulocyte colony-stimulating factor started two days before induction chemotherapy in refractory acute myeloid leukemia. Blood, 83, 2086-2092.
22. Orita, M., Suzuki, Y., Sekiya, T. & Hayashi, K. (1989) Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics, 5, 874-879.
23. Radich, J.P., Kopecky, K.J., Willman, C.L., Weick, J., Head, D. & Appelbaum, F. (1990) N-ras mutations in adult de novo acute myelogenous leukemia: prevelance and clinical significance. Blood, 76, 801-807.
24. Scuderi, R., Palucka, K.A., Pokrovskaja, K., Bjorkholm, M., Wiman, K.G. & Pisa, P. (1996) Cyclin E overexpression in relapsed adult acute lymphoblastic leukemias of B-cell lineage. Blood, 87, 3360-3367.
25. Wattel, E., Preudhomme, C., Hecquet, B., Vanrumbeke, M., Quesnel, B. & Dervite, I. (1994) p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies. Blood, 84, 3148-3157.
26. Yokota, S., Kiyoi, H., Nakao, M., Iwai, T., Misawa, S., Okuda, T., Sonoda, Y., Abe, T., Kashima, K., Matsuo, Y. & Naoe, T. (1997) Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies: a study on a large series of patients and cell lines. Leukemia, 11, 1605-1609.